Wolverine Trading’s DMK Pharmaceuticals DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-151
Closed -$2K – 5322
2022
Q3
$2K Buy
+151
New +$3.9K ﹤0.01% 4488
2022
Q1
– Sell
-419
Closed -$17K – 6732
2021
Q4
$17K Sell
419
-272
-39% -$17K ﹤0.01% 5518
2021
Q3
$46K Buy
+691
New +$50.6K ﹤0.01% 6031
2021
Q2
– Sell
-617
Closed -$40K – 6931
2021
Q1
$40K Buy
+617
New +$48.1K ﹤0.01% 5696
2018
Q4
– Sell
-494
Closed -$121K – 5565
2018
Q3
$121K Buy
494
+137
+38% +$32.4K ﹤0.01% 4470
2018
Q2
$88K Hold
357
– – ﹤0.01% 4769
2018
Q1
$88K Buy
+357
New +$93.7K ﹤0.01% 4769
2017
Q4
– Sell
-744
Closed -$272K – 5657
2017
Q3
$272K Buy
+744
New +$264K ﹤0.01% 3400
2017
Q2
– Sell
-536
Closed -$159K – 5149
2017
Q1
$159K Buy
536
+379
+241% +$95.6K ﹤0.01% 3659
2016
Q4
$35K Sell
157
-107
-41% -$21.5K ﹤0.01% 4262
2016
Q3
$60K Buy
+264
New +$54.9K ﹤0.01% 4365

Other funds holding DMK

Wolverine Trading's DMK Position: Q1 2022 in Review

Wolverine Trading sold out of DMK Pharmaceuticals (DMK) in Q1 2022, closing a stake of 209 shares — an estimated $9K sold.

Wolverine Trading first reported a position in DMK in Q4 2016 and held it in 10 quarters. The position peaked at $195K in Q4 2017. 46 funds tracked by Wall St. Rank hold DMK as of Q1 2022.

  • Wolverine Trading reported no remaining DMK Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Wolverine Trading sold 209 DMK Pharmaceuticals shares in Q1 2022, an estimated $9K.
  • Wolverine Trading first reported a position in DMK Pharmaceuticals in Q4 2016 and held it in 10 quarters.
  • Wolverine Trading's DMK Pharmaceuticals position peaked at $195K in Q4 2017.
  • 46 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q1 2022.

Based on Wolverine Trading's 13F filing for Q1 2022, filed 16 May 2022.